• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹与周效磺胺-乙胺嘧啶对孕妇和儿童的疗效比较:一项荟萃分析。

Comparative efficacy of chloroquine and sulphadoxine--pyrimethamine in pregnant women and children: a meta-analysis.

作者信息

Kalanda Gertrude C, Hill Jenny, Verhoeff Francine H, Brabin Bernard J

机构信息

Child and Reproductive Health Group, Liverpool School of Tropical Medicine, and Royal Liverpool Children's Hospital NHS Trust, UK.

出版信息

Trop Med Int Health. 2006 May;11(5):569-77. doi: 10.1111/j.1365-3156.2006.01608.x.

DOI:10.1111/j.1365-3156.2006.01608.x
PMID:16640608
Abstract

OBJECTIVE

To compare the efficacy of chloroquine and sulphadoxine-pyremethamine against Plasmodium falciparum infection in pregnant women and in children from the same endemic areas of Africa, with the aim of determining the level of correspondence in efficacy determinations in these two risk groups.

METHODS

Meta-analysis of nine published and unpublished in vivo antimalarial efficacy studies in pregnant women and in children across five African countries.

RESULTS

Pregnant women (all gravidae) were more likely to be sensitive than children to both chloroquine (odds ratio: 2.07; 95% confidence interval: 1.5, 2.9) and sulphadoxine-pyrimethamine (odds ratio: 2.66; 95% confidence interval: 11.1, 6.7). Pregnant women demonstrated an almost uniform increased sensitivity for peripheral parasite clearance at day 14 compared with children. This finding was consistent across a wide range of drug sensitivities. Primigravidae at day 14 showed lower clearance to antimalarial drugs than multigravidae (P<0.05). There was no significant difference between parasite clearance in primigravidae and in children.

CONCLUSION

The greater drug sensitivity in pregnant women probably indicates differences in host susceptibility rather than parasite resistance. Parasite sensitivity patterns in children may be a suitable guide to antimalarial policy in pregnant women.

摘要

目的

比较氯喹和周效磺胺-乙胺嘧啶对非洲同一疟疾流行地区孕妇和儿童恶性疟原虫感染的疗效,以确定这两个风险群体疗效判定中的一致性水平。

方法

对五个非洲国家已发表和未发表的九项关于孕妇和儿童体内抗疟疗效的研究进行荟萃分析。

结果

孕妇(所有孕期)对氯喹(优势比:2.07;95%置信区间:1.5,2.9)和周效磺胺-乙胺嘧啶(优势比:2.66;95%置信区间:11.1,6.7)的敏感性均高于儿童。与儿童相比,孕妇在第14天外周血寄生虫清除率的敏感性几乎一致提高。这一发现在所研究的广泛药物敏感性范围内均一致。初产妇在第14天对抗疟药物的清除率低于经产妇(P<0.05)。初产妇和儿童的寄生虫清除率无显著差异。

结论

孕妇较高的药物敏感性可能表明宿主易感性存在差异,而非寄生虫耐药性。儿童的寄生虫敏感性模式可能是孕妇抗疟政策的合适指导。

相似文献

1
Comparative efficacy of chloroquine and sulphadoxine--pyrimethamine in pregnant women and children: a meta-analysis.氯喹与周效磺胺-乙胺嘧啶对孕妇和儿童的疗效比较:一项荟萃分析。
Trop Med Int Health. 2006 May;11(5):569-77. doi: 10.1111/j.1365-3156.2006.01608.x.
2
Comparison of the therapeutic efficacy of chloroquine and sulphadoxine-pyremethamine in children and pregnant women.氯喹与周效磺胺-乙胺嘧啶对儿童及孕妇的治疗效果比较
Trop Med Int Health. 2007 Nov;12(11):1288-97. doi: 10.1111/j.1365-3156.2007.01927.x. Epub 2007 Oct 22.
3
Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.氯喹与其他抗疟药物的疗效及安全性比较:来自六个非洲国家的荟萃分析
East Afr Med J. 1999 Jun;76(6):314-9.
4
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.在恶性疟原虫和间日疟原虫共同流行地区,磺胺多辛-乙胺嘧啶联合青蒿琥酯与氯喹治疗间日疟的疗效比较:阿富汗东部的一项随机非劣效性试验
Trans R Soc Trop Med Hyg. 2007 Nov;101(11):1081-7. doi: 10.1016/j.trstmh.2007.06.015. Epub 2007 Aug 17.
5
In vivo and in vitro response of Plasmodium falciparum to chloroquine in pregnant women in Kilifi district, Kenya.肯尼亚基利菲区孕妇体内恶性疟原虫对氯喹的体内和体外反应
East Afr Med J. 1992 Jun;69(6):306-10.
6
Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.氯喹与周效磺胺-乙胺嘧啶用于治疗老挝人民民主共和国沙湾拿吉省恶性疟原虫疟疾:对国家抗疟药物推荐的评估
Clin Infect Dis. 2003 Oct 15;37(8):1021-8. doi: 10.1086/377734. Epub 2003 Sep 25.
7
Efficacy of chloroquine and sulfadoxine/pyrimethamine mono- and combined therapy against falciparum malaria in Sudan.氯喹及磺胺多辛/乙胺嘧啶单药治疗与联合治疗对苏丹恶性疟的疗效
East Mediterr Health J. 2007 Jan-Feb;13(1):25-34.
8
The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis.磺胺多辛-乙胺嘧啶单药及与氯喹联合用于苏丹东部农村地区疟疾治疗的疗效:耐药性、年龄与配子体形成之间的相互关系
Trop Med Int Health. 2006 May;11(5):604-12. doi: 10.1111/j.1365-3156.2006.01616.x.
9
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.青蒿琥酯加阿莫地喹、青蒿琥酯加磺胺多辛-乙胺嘧啶以及氯喹加磺胺多辛-乙胺嘧啶在科摩罗联盟非复杂性恶性疟患者中的疗效。
Acta Trop. 2007 Jun;102(3):176-81. doi: 10.1016/j.actatropica.2007.03.004. Epub 2007 May 3.
10
Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control.感染艾滋病毒的孕妇中疟疾患病率上升及其对疟疾控制的影响。
Trop Med Int Health. 1999 Jan;4(1):5-12. doi: 10.1046/j.1365-3156.1999.00349.x.

引用本文的文献

1
Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Sub-Saharan Africa-A Review.撒哈拉以南非洲地区氯喹和磺胺多辛-乙胺嘧啶耐药性综述
Front Genet. 2021 Jun 25;12:668574. doi: 10.3389/fgene.2021.668574. eCollection 2021.
2
The Impact of Nutrition-Specific and Nutrition-Sensitive Interventions on Hemoglobin Concentrations and Anemia: A Meta-review of Systematic Reviews.营养特异性和营养敏感性干预措施对血红蛋白浓度和贫血的影响:系统评价的元综述。
Adv Nutr. 2020 Nov 16;11(6):1631-1645. doi: 10.1093/advances/nmaa070.
3
The potential of pregnant women as a sentinel population for malaria surveillance.
孕妇作为疟疾监测哨点人群的潜力。
Malar J. 2019 Nov 21;18(1):370. doi: 10.1186/s12936-019-2999-0.
4
Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial.西非孕期间歇性筛查后治疗与间歇性预防治疗的成本效益:一项非劣效性试验结果的分析与建模
Malar J. 2016 Sep 23;15(1):493. doi: 10.1186/s12936-016-1539-4.
5
User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya.肯尼亚西部间歇性筛查与治疗以及双氢青蒿素哌喹间歇性预防治疗预防疟疾在孕期的使用者和提供者的可接受性
PLoS One. 2016 Mar 17;11(3):e0150259. doi: 10.1371/journal.pone.0150259. eCollection 2016.
6
Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review and meta-analysis.孕妇与儿童疟疾感染率比较在撒哈拉以南非洲追踪疟疾传播中的应用:系统评价和荟萃分析。
Lancet Glob Health. 2015 Oct;3(10):e617-28. doi: 10.1016/S2214-109X(15)00049-2. Epub 2015 Aug 19.
7
Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.在布基纳法索和马里,使用周效磺胺-乙胺嘧啶进行间歇性预防治疗后寄生虫清除情况:42天体内随访研究。
Malar J. 2014 Jan 31;13:41. doi: 10.1186/1475-2875-13-41.
8
Factors associated with risk of malaria infection among pregnant women in Lagos, Nigeria.尼日利亚拉各斯孕妇疟疾感染风险相关因素。
Infect Dis Poverty. 2013 Aug 30;2(1):19. doi: 10.1186/2049-9957-2-19.
9
Monitoring antifolate resistance in intermittent preventive therapy for malaria.监测间歇性预防疗法治疗疟疾中的抗叶酸耐药性。
Trends Parasitol. 2013 Oct;29(10):497-504. doi: 10.1016/j.pt.2013.07.008. Epub 2013 Aug 12.
10
In-vivo parasitological response to sulfadoxine-pyrimethamine in pregnant women in southern Malawi.马拉维南部孕妇对磺胺多辛-乙胺嘧啶的体内寄生虫学反应
Malawi Med J. 2007 Mar;19(1):11-3. doi: 10.4314/mmj.v19i1.10926.